Literature DB >> 10078744

Neuro-ophthalmologic manifestations of a paraneoplastic syndrome and testicular carcinoma.

J L Bennett1, S L Galetta, L P Frohman, Z Mourelatos, S H Gultekin, J O Dalmau, J B Posner.   

Abstract

The authors report two patients with testicular cancer who exhibited supranuclear gaze disorders as a manifestation of a paraneoplastic brainstem encephalomyelitis. In the first patient, neuro-ophthalmic dysfunction was accompanied by a prominent limbic encephalitis whereas in the second patient, an unusual, mixed pendular and jerk nystagmus was manifested. Neuroimaging revealed an enhancing hypothalamic mass in the first patient and was negative in the second. Blood from both patients contained an antibody previously reported in a patient with limbic encephalitis and testicular cancer.

Entities:  

Mesh:

Year:  1999        PMID: 10078744     DOI: 10.1212/wnl.52.4.864

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  MR imaging of autopsy-proved paraneoplastic limbic encephalitis in non-Hodgkin lymphoma.

Authors:  Christina Thuerl; Klaus Müller; Jörg Laubenberger; Benedikt Volk; Mathias Langer
Journal:  AJNR Am J Neuroradiol       Date:  2003-03       Impact factor: 3.825

Review 2.  Movement disorders in paraneoplastic and autoimmune disease.

Authors:  Jessica Panzer; Josep Dalmau
Journal:  Curr Opin Neurol       Date:  2011-08       Impact factor: 5.710

3.  Focal paraneoplastic limbic encephalitis presenting as orgasmic epilepsy.

Authors:  C E Fadul; E W Stommel; K H Dragnev; C J Eskey; J O Dalmau
Journal:  J Neurooncol       Date:  2005-04       Impact factor: 4.130

4.  Paraneoplastic vertigo as the presenting symptom of a testicular seminoma.

Authors:  Andrea Ball; Emma B Greer; Christopher J Wong
Journal:  BMJ Case Rep       Date:  2014-11-05

5.  Treatment of anti-Ma2/Ta paraneoplastic syndrome.

Authors:  Jessica Kraker
Journal:  Curr Treat Options Neurol       Date:  2009-01       Impact factor: 3.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.